Page last updated: 2024-10-21

acemetacin and Diabetes Mellitus, Type 2

acemetacin has been researched along with Diabetes Mellitus, Type 2 in 1 studies

acemetacin : A carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used in the treatment of rheumatoid arthritis, osteoarthritis, and low back pain, as well as for postoperative pain and inflammation. Its activity is due to both acemetacin and its major metabolite, indometacin.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
" When treating Bartter's syndrome, it is also prudent to remember that the long-term use of nonsteroidal anti-inflammatory drugs and potassium-sparing diuretics may result in serious adverse reactions."1.35Bartter's syndrome with type 2 diabetes mellitus. ( Lee, SP; See, TT, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
See, TT1
Lee, SP1

Other Studies

1 other study available for acemetacin and Diabetes Mellitus, Type 2

ArticleYear
Bartter's syndrome with type 2 diabetes mellitus.
    Journal of the Chinese Medical Association : JCMA, 2009, Volume: 72, Issue:2

    Topics: Adult; Bartter Syndrome; Celecoxib; Diabetes Mellitus, Type 2; Female; Humans; Indomethacin; Pyrazol

2009